Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from BrainChip Holdings ( (AU:BRN) ).
BrainChip has scheduled its 2026 Annual General Meeting for 6 May in Sydney, and set 12 March as the deadline for shareholders to submit written nominations for board seats with the consent of proposed directors. The formal meeting notice will follow, and the AGM process underscores ongoing governance and board renewal at the neuromorphic Edge AI specialist as it advances commercial deployment of its Akida technology across multiple industries.
The timetable for director nominations provides clarity for investors and potential board candidates ahead of the May meeting, where shareholders will help shape the company’s leadership. This governance milestone comes as BrainChip positions its ultra-low power AI IP and processors for broader adoption at the network edge, a segment attracting growing interest from industrial, automotive, and consumer technology stakeholders.
The most recent analyst rating on (AU:BRN) stock is a Hold with a A$0.13 price target. To see the full list of analyst forecasts on BrainChip Holdings stock, see the AU:BRN Stock Forecast page.
More about BrainChip Holdings
BrainChip Holdings is a semiconductor and IP company specializing in ultra‑low power, fully digital neuromorphic AI technology for edge computing. Its flagship Akida processor and Temporal Event-based Neural Networks apply event-driven, brain-inspired computing to deliver efficient, real-time intelligence for applications in aerospace, autonomous vehicles, robotics, industrial IoT, consumer devices, and wearables.
Average Trading Volume: 8,637,843
Technical Sentiment Signal: Sell
Current Market Cap: A$301.2M
See more data about BRN stock on TipRanks’ Stock Analysis page.